Home/Filings/4/0000950170-25-096674
4//SEC Filing

Jerman Michael Allen 4

Accession 0000950170-25-096674

CIK 0001107421other

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 5:35 PM ET

Size

7.9 KB

Accession

0000950170-25-096674

Insider Transaction Report

Form 4
Period: 2025-07-15
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-07-15+10,00010,000 total
    Exercise: $3.40Exp: 2035-07-14Common Stock (10,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2025-07-15+3,2003,200 total
    Exercise: $3.40Exp: 2035-07-14Common Stock (3,200 underlying)
Footnotes (2)
  • [F1]One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date.
  • [F2]One-twelfth of the Option vests each month on the monthly anniversary of July 15, 2025, with any amount that remains unvested on the date immediately preceding the Company's 2026 annual general meeting of stockholders vesting thereon. Vesting shall accelerate in full upon Optionholder's death or Disability or a Change of Control.

Documents

1 file

Issuer

Alaunos Therapeutics, Inc.

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001979732

Filing Metadata

Form type
4
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:35 PM ET
Size
7.9 KB